SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001610618-17-000018
Filing Date
2017-03-31
Accepted
2017-03-31 17:08:54
Documents
1
Period of Report
2017-03-30
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT - CARB-X cdtx8-k2017x03x31.htm 8-K 18456
  Complete submission text file 0001610618-17-000018.txt   19661
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36912 | Film No.: 17731276
SIC: 2836 Biological Products, (No Diagnostic Substances)